Introduced
Committee
Markup
Reported
Floor
Passed
Enacted
HR.795 119th Congress

Pregnancy Is Not an Illness Act of 2025

Status
In Committee
Latest Action
2025-01-28
Sponsor
Miller, Mary E. (R-Illinois)
Official Source
Investability
41/100
Stage
COMMITTEE
Related Bills
0
Full Text
1,902 chars
Alive
Yes
GovGreed Synthesis ·
Pregnancy Is Not an Illness Act of 2025 This bill prohibits the Food and Drug Administration (FDA) from treating pregnancy as an illness for the purposes of approving any abortion drug or imposing a risk evaluation and mitigation strategy for an abortion drug. The bill also nullifies FDA approval of any abortion drug that relied at all on the treatment of pregnancy as an illness, and specifically nullifies the FDA’s approval of the abortion drug mifepristone in effect before the bill is enacted.
2025-01-28
Referred to the House Committee on Energy and Commerce.
2025-01-28
Introduced in House
2025-01-28
Introduced in House
119 HR 795 IH: Pregnancy Is Not an Illness Act of 2025 U.S. House of Representatives 2025-01-28 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 795 IN THE HOUSE OF REPRESENTATIVES January 28, 2025 Mrs. Miller of Illinois (for herself, Mr. Babin , Mr. Moore of West Virginia , Mr. Ogles , Mr. Webster of Florida , Ms. Tenney , Mr. Harris of Maryland , and Mr. Weber of Texas ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prohibit the Department of Health and Human Services from treating pregnancy as an illness for purposes of approving abortion drugs. 1. Short title This Act may be cited as the Pregnancy Is Not an Illness Act of 2025 . 2. Prohibition against treating pregnancy as illness for purposes of approving abortion drugs (a) Prohibition The Department of Health and Human Services, including the Food and Drug Administration, shall not treat pregnancy as an illness for purposes of— (1) approving any abortion drug under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ); or (2) imposing or maintaining any risk evaluation and mitigation strategy for an abortion drug under section 505–1 of such Act ( 21 U.S.C. 355–1 ). (b) Nullification of approvals in effect (1) In general Any prohibited approval of an abortion drug is hereby nullified. (2) Prohibited approval defined In this subsection, the term prohibited approval of an abortion drug — (A) means any approval of an abortion drug under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) that relied in whole or in part on the treatment of pregnancy as illness; and (B) includes the approval of mifepristone in effect under such section 505 on the day before the date of enactment of this Act.
🔒 GovGreed Pro · Trading Intelligence on HR.795 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated recently.
Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records.
GovGreed is not affiliated with the U.S. Government. Not financial advice.